Detailsuche

Olek

Multiple Sclerosis

Etiology, Diagnosis, and New Treatment Strategies
2004. Buch. xvi, 246 S.: 36 s/w-Abbildungen, Bibliographien. Hardcover
Humana Press ISBN 978-1-58829-033-5
Format (B x L): 15,5 x 23,5 cm
Gewicht: 548 g
In englischer Sprache
Das Werk ist Teil der Reihe:
Nachauflage:
A synthesis of current concepts about the evaluation, treatment, and future directions in MS. On the evaluation side, the authors review the use of MRI, magnetic resonance spectroscopy, functional MRI, and three-dimensional MRI, and consider the rapidly developing body of pathologic information they have yielded. On the treatment side, the focus is on recently approved medications (Novantrone), new indications for medications (CHAMPS Trial), medications in development (Oral Interferon Tau, Oral Copaxone, and Oral Cellcept), immunosuppressive therapy for both progressive disease and symptomatic therapy; the current medications for treating relapsing-remitting MS (Avonex, Betaseron, and Copaxone) are also discussed. For future directions, the authors present the current best thinking, as well as the latest discoveries in immunology relating to MS, including groundbreaking B-cell research and its applications to specific immunotherapies, and the use of immune markers for tracking the disease.

Audience

Research

Versandkostenfrei
lieferbar, ca. 4 Wochen
160,49 €
inkl. MwSt.
Webcode: beck-shop.de/bckgd
Herausgegeben von: link iconMichael Olek